ACH is caused by a recurrent dominant pathogenic variant within the fibroblast growth factor receptor 3 gene (FGFR3) [1, 3], which leads to the inhibition of endochondral bone growth [4]. This evidence concerns the gene FGFR3 and achondroplasia.